Health Care Excipients - Solubilizers for High-Risk Applications
In recent years, the number of sensitive pharmaceutical drug delivery systems approved by the U.S. Food and Drug Administration has increased significantly and is expected to increase further as the overall drug market expands and new therapies for both chronic and rare diseases enter the pipeline.
How can Clariant help you to get a solution for these kinds of formulations? We offer a wide range of low bioburden and low elemental impurities excipients for sensitive APIs and formulations:
- PEGs
- PEG-Derivatives
With these extended product specifications, Clariant can assist you in creating your individual formulation risk assessment.